CN107670097B - 一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 - Google Patents
一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 Download PDFInfo
- Publication number
- CN107670097B CN107670097B CN201710976817.6A CN201710976817A CN107670097B CN 107670097 B CN107670097 B CN 107670097B CN 201710976817 A CN201710976817 A CN 201710976817A CN 107670097 B CN107670097 B CN 107670097B
- Authority
- CN
- China
- Prior art keywords
- oligopeptide
- dressing
- percent
- ginseng
- material solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010038807 Oligopeptides Proteins 0.000 title claims abstract description 165
- 102000015636 Oligopeptides Human genes 0.000 title claims abstract description 165
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 56
- 206010052428 Wound Diseases 0.000 title claims abstract description 55
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 230000001737 promoting effect Effects 0.000 title claims abstract description 32
- 230000029663 wound healing Effects 0.000 title claims abstract description 27
- 238000000605 extraction Methods 0.000 claims abstract description 64
- 241000208340 Araliaceae Species 0.000 claims abstract description 41
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 41
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 41
- 235000008434 ginseng Nutrition 0.000 claims abstract description 41
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 66
- 241000251511 Holothuroidea Species 0.000 claims description 52
- 238000003756 stirring Methods 0.000 claims description 48
- 239000007788 liquid Substances 0.000 claims description 47
- 238000000926 separation method Methods 0.000 claims description 45
- 210000000988 bone and bone Anatomy 0.000 claims description 44
- 230000001954 sterilising effect Effects 0.000 claims description 40
- 241000283690 Bos taurus Species 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000004659 sterilization and disinfection Methods 0.000 claims description 32
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- 239000012528 membrane Substances 0.000 claims description 26
- 239000000047 product Substances 0.000 claims description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 238000000108 ultra-filtration Methods 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 239000008213 purified water Substances 0.000 claims description 18
- 238000001694 spray drying Methods 0.000 claims description 18
- 238000011049 filling Methods 0.000 claims description 16
- 238000004806 packaging method and process Methods 0.000 claims description 16
- 230000000975 bioactive effect Effects 0.000 claims description 15
- 230000035876 healing Effects 0.000 claims description 14
- 239000003906 humectant Substances 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000011664 nicotinic acid Substances 0.000 claims description 12
- 238000009826 distribution Methods 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 239000003961 penetration enhancing agent Substances 0.000 claims description 11
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 9
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- 229940116229 borneol Drugs 0.000 claims description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 229940041616 menthol Drugs 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 108090000145 Bacillolysin Proteins 0.000 claims description 7
- 108091005658 Basic proteases Proteins 0.000 claims description 7
- 108091005507 Neutral proteases Proteins 0.000 claims description 7
- 102000035092 Neutral proteases Human genes 0.000 claims description 7
- 238000010907 mechanical stirring Methods 0.000 claims description 7
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 7
- 235000019477 peppermint oil Nutrition 0.000 claims description 7
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 2
- 230000002980 postoperative effect Effects 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 239000000022 bacteriostatic agent Substances 0.000 abstract description 2
- 235000003715 nutritional status Nutrition 0.000 abstract description 2
- 241000965254 Apostichopus japonicus Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 51
- 102000004190 Enzymes Human genes 0.000 description 44
- 108090000790 Enzymes Proteins 0.000 description 44
- 229940088598 enzyme Drugs 0.000 description 44
- 230000003385 bacteriostatic effect Effects 0.000 description 18
- 238000001035 drying Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 238000005352 clarification Methods 0.000 description 14
- 230000009849 deactivation Effects 0.000 description 14
- 230000000415 inactivating effect Effects 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 239000000126 substance Substances 0.000 description 9
- 238000013375 chromatographic separation Methods 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 230000002757 inflammatory effect Effects 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 6
- 108090001005 Interleukin-6 Proteins 0.000 description 6
- 108090001007 Interleukin-8 Proteins 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000004302 potassium sorbate Substances 0.000 description 6
- 229940069338 potassium sorbate Drugs 0.000 description 6
- 235000010241 potassium sorbate Nutrition 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 229940040145 liniment Drugs 0.000 description 5
- 239000000865 liniment Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 3
- 241000258955 Echinodermata Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 108010007119 flavourzyme Proteins 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010054044 Diabetic microangiopathy Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910003471 inorganic composite material Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710976817.6A CN107670097B (zh) | 2017-10-19 | 2017-10-19 | 一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710976817.6A CN107670097B (zh) | 2017-10-19 | 2017-10-19 | 一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107670097A CN107670097A (zh) | 2018-02-09 |
CN107670097B true CN107670097B (zh) | 2021-02-23 |
Family
ID=61141692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710976817.6A Expired - Fee Related CN107670097B (zh) | 2017-10-19 | 2017-10-19 | 一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107670097B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110613832B (zh) * | 2019-10-31 | 2022-03-22 | 西安惠普生物科技有限公司 | 一种海参多肽在医疗器械的应用和制备方法 |
CN111249300B (zh) * | 2020-02-11 | 2021-03-26 | 山东大学 | 褪黑素联合甲钴胺在治疗糖尿病创面愈合障碍中的应用 |
CN111437433A (zh) * | 2020-05-08 | 2020-07-24 | 海南卓瑞生物医药有限公司 | 皮肤护理敷料制备方法及皮肤护理敷料 |
CN111388740B (zh) * | 2020-05-21 | 2021-09-10 | 南通大学 | 一种促伤口愈合敷料及其制备方法 |
CN113995885A (zh) * | 2021-09-29 | 2022-02-01 | 浙江美尚洁生物科技有限公司 | 重组纤连-胶原蛋白多功能医用复合材料及其制备方法 |
CN113750119A (zh) * | 2021-10-11 | 2021-12-07 | 山东第一医科大学附属省立医院(山东省立医院) | 一种具有治疗糖尿病足的外用制剂及其制备工艺 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04364200A (ja) * | 1991-06-10 | 1992-12-16 | Unitika Ltd | 細胞接着性アルブミン |
WO2003017989A1 (en) * | 2001-08-23 | 2003-03-06 | Scimed Life Systems, Inc. | Compositions and techniques for localized therapy of restenosis |
CN101648002A (zh) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | 一种用于治疗皮肤破损溃疡的药物组合物及其应用 |
CN103937860A (zh) * | 2014-03-26 | 2014-07-23 | 刘凯 | 促进术后伤口愈合的海参肽的制备方法 |
CN104109705A (zh) * | 2014-06-19 | 2014-10-22 | 广东省农业科学院蚕业与农产品加工研究所 | 一种酶法制备具有促进伤口愈合活性的海洋胶原蛋白肽的方法 |
CN105132498A (zh) * | 2015-07-30 | 2015-12-09 | 北京天肽生物科技有限公司 | 一种小分子海参肽及其制备方法 |
CN105311061A (zh) * | 2014-05-31 | 2016-02-10 | 陈光健 | 一种具有创面修复作用的药物组合物及其制备方法和应用 |
CN106726669A (zh) * | 2016-11-18 | 2017-05-31 | 名臣健康用品股份有限公司 | 一种含有海参多肽的抗衰老化妆品基质及其制备方法 |
-
2017
- 2017-10-19 CN CN201710976817.6A patent/CN107670097B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04364200A (ja) * | 1991-06-10 | 1992-12-16 | Unitika Ltd | 細胞接着性アルブミン |
WO2003017989A1 (en) * | 2001-08-23 | 2003-03-06 | Scimed Life Systems, Inc. | Compositions and techniques for localized therapy of restenosis |
CN101648002A (zh) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | 一种用于治疗皮肤破损溃疡的药物组合物及其应用 |
CN103937860A (zh) * | 2014-03-26 | 2014-07-23 | 刘凯 | 促进术后伤口愈合的海参肽的制备方法 |
CN105311061A (zh) * | 2014-05-31 | 2016-02-10 | 陈光健 | 一种具有创面修复作用的药物组合物及其制备方法和应用 |
CN104109705A (zh) * | 2014-06-19 | 2014-10-22 | 广东省农业科学院蚕业与农产品加工研究所 | 一种酶法制备具有促进伤口愈合活性的海洋胶原蛋白肽的方法 |
CN105132498A (zh) * | 2015-07-30 | 2015-12-09 | 北京天肽生物科技有限公司 | 一种小分子海参肽及其制备方法 |
CN106726669A (zh) * | 2016-11-18 | 2017-05-31 | 名臣健康用品股份有限公司 | 一种含有海参多肽的抗衰老化妆品基质及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107670097A (zh) | 2018-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107670097B (zh) | 一种促进糖尿病伤口愈合的低聚肽创面敷料及其制备方法 | |
CN107648205B (zh) | 一种促进伤口愈合的胶原肽敷料及其制备方法 | |
JP6496393B2 (ja) | 天然ビタミンcとコラーゲンペプチドの組成物及びその製造方法 | |
KR20140034938A (ko) | 복합 콜라겐 스폰지 및 그의 제조방법 | |
CN110638836A (zh) | 一种水溶性珍珠粉在促进伤口愈合的应用 | |
CN113698472B (zh) | 一种高纯度小分子鱼皮胶原蛋白肽的制备方法以及鱼皮胶原蛋白肽喷雾剂 | |
CN108939140A (zh) | 一种用于止血的组合物及医用止血敷料 | |
EP1940478B1 (en) | Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate | |
CN109700998B (zh) | 一种复方肌肤损伤再生修复剂及其制备方法 | |
CN104825349A (zh) | 一种由生物质原料制作的皮肤护理凝胶敷剂的生产方法 | |
KR20180028229A (ko) | 고농도, 고순도의 동종 콜라겐 제조 방법 및 동종 콜라겐 지지체의 제조방법 | |
JP2005075743A (ja) | ダイズ種子からの揮発性画分及び組成物 | |
KR101252023B1 (ko) | 대두 종자로부터의 휘발성 분획 및 조성물 | |
US20080102106A1 (en) | Wound Healing Composition Comprising Substances From Diptera Larvae | |
CN1246021C (zh) | 治疗外伤用的药贴及其制备方法和用途 | |
KR20180060542A (ko) | 키토산하이드로겔 및 pdrn을 함유하는 조직재생력이 강화된 창상피복재 및 그 도포제 | |
US20110189222A1 (en) | Composition for wound healing | |
CN106048766B (zh) | 一种含蚕丝蛋白的防腐生肌面料及其制备方法 | |
CN112675354B (zh) | 一种多功能白及医用材料及其制备方法与应用 | |
CN108635620A (zh) | 一种具有抗菌止血功效的医用生物敷料及其制备方法 | |
KR101936288B1 (ko) | 동결건조 콜라겐 솔루션을 이용한 마스크 시트의 제조방법 | |
CN105561382A (zh) | 一种铁皮石斛液体创可贴及其制备方法 | |
CN108671123A (zh) | 一种治疗脚气的喷雾剂及其提取技术 | |
CN114057831B (zh) | 促进血管增生的短链胜肽及其促进糖尿病伤口愈合的用途 | |
CN114569513B (zh) | 一种祛痘抑菌护肤品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 466200 Industrial Agglomeration Zone of Xiangcheng City, Zhoukou City, Henan Province Applicant after: Beijing Jiuding Junjiandong Peptide Biotechnology City Co.,Ltd. Applicant after: Li Yong Address before: 466200 Industrial Agglomeration Zone of Xiangcheng City, Zhoukou City, Henan Province Applicant before: BEIJING JIUDING JUNJIAN PHARMACEUTICAL TECHNOLOGY XIANGCHENG Co.,Ltd. Applicant before: Li Yong |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 466200 Industrial Agglomeration Zone of Xiangcheng City, Zhoukou City, Henan Province Patentee after: Henan dongpeptide biology Co.,Ltd. Patentee after: Li Yong Address before: 466200 Industrial Agglomeration Zone of Xiangcheng City, Zhoukou City, Henan Province Patentee before: Beijing Jiuding Junjiandong Peptide Biotechnology City Co.,Ltd. Patentee before: Li Yong |
|
CP01 | Change in the name or title of a patent holder | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210223 |
|
CF01 | Termination of patent right due to non-payment of annual fee |